Insights on Drug levels and Non-Sustained Viral Suppression with Long-Acting Cabotegravir and Rilpivirine Therapy

Clin Infect Dis. 2024 Dec 13:ciae617. doi: 10.1093/cid/ciae617. Online ahead of print.

Authors

Félix Gutiérrez^{1

2

3}, Marta Fernández-González^{1

3}, Christian Ledesma¹, María Losada-Echeberría⁴, Enrique Barrajón-Catalán⁴, Mar Masiá^{1

2

3}

Affiliations

¹ Infectious Diseases Unit, Hospital General Universitario de Elche, Elche, Spain.
² Department of Clinical Medicine, Universidad Miguel Hernández, Alicante, Spain.
³ CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
⁴ Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universidad Miguel Hernández, Elche, Spain.

PMID: 39673180
DOI: 10.1093/cid/ciae617

No abstract available